Evidence map›Paper›PMID 37479875›Full record

ArticleBiometrics2023

Constructing time-invariant dynamic surveillance rules for optimal monitoring schedules.

Xinyuan Dong, Yingye Zheng, Daniel W Lin, Lisa Newcomb, Ying-Qi Zhao

Abstract read
In one paragraph

Article in Biometrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xinyuan DongAmazon.com, Inc, Seattle, Washington, USA.
Yingye ZhengPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.ORCID 0000-0002-3078-4200
Daniel W LinPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Lisa NewcombPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Ying-Qi ZhaoPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.ORCID 0000-0002-2851-2257

Funding

The Early Detection Research Network: Data Management and Coordinating CenterU24CA086368 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI RUTH D ETZIONI, Ziding Feng · 2010 to 2026
$75.7M
High-Performance Compute Cluster for Comprehensive Cancer and Infectious Diseases ResearchS10OD028685 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI BRADLEY, PHILIP · 2020 to 2020
$2.0M
Statistical Methods for Prospective Evaluation of BiomarkersR01CA236558 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI ZHENG, YINGYE · 2019 to 2024
$1.9M
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
NCI NIH HHS R01 CA236558NCI NIH HHS U24 CA086368NIH HHS S10 OD020069NIH HHS S10 OD028685
6 · The paper itself

Abstract

Dynamic surveillance rules (DSRs) are sequential surveillance decision rules informing monitoring schedules in clinical practice, which can adapt over time according to a patient's evolving characteristics. In many clinical applications, it is desirable to identify and implement optimal time-invariant DSRs, where the parameters indexing the decision rules are shared across different decision points. We propose a new criterion for DSRs that accounts for benefit-cost tradeoff during the course of disease surveillance. We develop two methods to estimate the time-invariant DSRs optimizing the proposed criterion, and establish asymptotic properties for the estimated parameters of biomarkers indexing the DSRs. The first approach estimates the optimal decision rules for each individual at every stage via regression modeling, and then estimates the time-invariant DSRs via a classification procedure with the estimated time-varying decision rules as the response. The second approach proceeds by optimizing a relaxation of the empirical objective, where a surrogate function is utilized to facilitate computation. Extensive simulation studies are conducted to demonstrate the superior performances of the proposed methods. The methods are further applied to the Canary Prostate Active Surveillance Study (PASS).

Indexed as

Computer SimulationBiomarkersHumansMaleBiomarkersactive surveillancebenefit-cost tradeoffdynamic surveillance rulespersonalized medicine

Identifiers

PMID37479875
PMCPMC10866138

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.